Michael Gelband’s NEOPHOTONICS CORP NPTN Stock Holding History

Michael Gelband’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-13,124	Closed	-$202K	–	2845
2021 Q4	$202K	Sell	13,124 -17,439	-57%	-$229K	﹤0.01%	1824
2021 Q3	$266K	Buy	30,563 +9,630	+46%	+$87.8K	﹤0.01%	1666
2021 Q2	$214K	Buy	+20,933	New	+$221K	﹤0.01%	1947
2020 Q3	–	Sell	-109,193	Closed	-$970K	–	2381
2020 Q2	$970K	Buy	+109,193	New	+$941K	0.03%	760
2019 Q4	–	Sell	-12,700	Closed	-$77K	–	2003
2019 Q3	$77K	Buy	+12,700	New	+$71.4K	﹤0.01%	1255
2019 Q2	–	Sell	-17,597	Closed	-$111K	–	1414
2019 Q1	$111K	Buy	+17,597	New	+$123K	0.01%	609

Other funds holding NPTN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

WIC

Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return

Michael Gelband's NPTN Position: Q1 2022 in Review

Michael Gelband sold out of NEOPHOTONICS CORP (NPTN) in Q1 2022, closing a stake of 13,124 shares — an estimated $202K sold.

Michael Gelband first reported a position in NPTN in Q1 2019 and held it in 6 quarters. The position peaked at $970K in Q2 2020. 143 funds tracked by Wall St. Rank hold NPTN as of Q1 2022.

Michael Gelband reported no remaining NEOPHOTONICS CORP position as of Q1 2022 after selling out during the quarter.
Michael Gelband sold 13,124 NEOPHOTONICS CORP shares in Q1 2022, an estimated $202K.
Michael Gelband first reported a position in NEOPHOTONICS CORP in Q1 2019 and held it in 6 quarters.
Michael Gelband's NEOPHOTONICS CORP position peaked at $970K in Q2 2020.
143 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q1 2022.

Based on ExodusPoint Capital Management's 13F filing for Q1 2022, filed 13 May 2022.